Syncope in the Athlete

Syncope: Mechanisms and Management: Second Edition

Volumn , Issue , 2007, Pages 287-300

  Hedrich, Olaf ^a   Link, Mark S ^a   Homoud, Munther K ^a   Estes, N A Mark ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

Athletes; Cardiopulmonary resuscitation; Electrocardiography; Sudden cardiac death; Syncope

Indexed keywords

EID: 33749058172     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470994801.ch17     Document Type: Chapter

References (67)

1. Michaud GF, Wang PJ, Estes NAM. Syncope in the athlete. In: Estes NAM, Salem DN, Wang PJ, eds. Sudden Cardiac Death in the Athlete. Armonk, NY: Futura, 1998: 419-40.
2. Day SC, Cook EF, Funkenstein H, Goldman L. Evaluation and outcomes of emergency room patients with transient loss of consciousness. Am J Med 1982;73: 15-23.
3. Savage D, Corwin L, McGee D, Kannel WB, Wolf PA. Epidemiologic features of isolated syncope: the Framingham Study. Stroke 1985;16: 626-9.
4. Maron BJ. Sudden death in young athletes: lessons from the Hank Gathers affair. NEngl J Med 1993;329: 55-7.
5. Maron BJ, Mitten MJ, Quandt EK, Zipes DP. Competitive athletes with cardiovascular disease: the case of Nicholas Knapp. N Engl J Med 1998;339: 1632-5.
6. Maron BJ, Gohman TE, Aeppli D. Prevalence of sudden cardiac death during competitive sports activities in Minnesota high school athletes. J Am Coll Cardiol 1998;32: 1881-4.
7. Kramer MR, Drori Y, Lev B. Sudden death in young soldiers: high incidence of syncope prior to death. Chest 1988;93: 345-7.
8. Maron BJ, Roberts WC, McCallister WA, et al. Sudden death in young athletes. Circulation 1980;62: 218-29.
9. Goldschlager N, Epstein AE, Grubb BP, et al. Etiologic considerations in the patient with syncope and an apparently normal heart. Arch Intern Med 2003;163: 151-62.
10. Link MS, Homoud MK, Wang PJ, Estes NAM. Syncope in athletes. Cardiovasc Rev Rep2002;23: 625-32.
11. Estes NAM, Link MS, Cannom D, et al. Report of the NASPE policy conference on arrhythmias and the athlete. J Cardiovasc Electrophysiol 2001;12: 1208-19.
12. Maron BJ, Mitchel JH. Revised eligibility recommendations for competitive athletes with cardiovascular abnormalities. J Am Coll Cardiol 1994;24: 848-50.
13. Mitchell JH, Haskell WH, Raven PB. Classification of sports. J Am Coll Cardiol 1994;24: 864-6.
14. Pluim BM, Zwinderman AH, van der Laarse A, van der Wall EE. The athlete's heart: a meta-analysis of cardiac structure and function. Circulation 2000;101: 336-44.
15. Maron BJ, Pelliccia A, Spirito P. Cardiac disease in young trained athletes: insights into methods for distinguishing athlete's heart from structural heart disease with particular emphasis on hypertrophic cardiomyopathy. Circulation 1995;91: 1596-601.
16. Pelliccia A, Maron BJ, De Luca R, Di Paolo FM, Spataro A, Culasso F. Remodeling of left ventricular hypertrophy in elite athletes after long-term deconditioning. Circulation 2002;105: 944-9.
17. Pelliccia A, Maron BJ, Culasso F, et al. Clinical significance of abnormal electrocardiographic patterns in trained athletes. Circulation 2000;102: 278-84.
18. Estes NAM, Link ML, Homoud M, Wang PJ. Electrocardiographic variants and cardiac rhythm and conduction distribution in the athlete. In: Thompson PW, ed. Textbook of Sports Physiology. New York: McGraw Hill, 2001.
19. Olshansky B. Syncope: Overview and approach to management. In Grubb BP, Olshansky B, eds. Syncope: Mechanisms and Management.Armonk, NY: Futura, 1998: 15-71.
20. Calkins H, Zipes DP. Hypotension and syncope. In: Braunwald E, Zipes DP, Libby P, eds. Heart Disease: A Textbook of Cardiovascular Medicine, 6th edn. Philadelphia, PA: W.B. Saunders, 2001: 932-40.
21. Maron BJ. Sudden death in young athletes. N Engl J Med 2003;349: 1064-75.
22. Burke AP, Farb A, Virmani R. Causes of sudden death in athletes. Cardiol Clin 1992;10: 303-17.
23. Maron BJ. Cardiovascular risks to young persons on the athletic field. Ann Intern Med 1998;129: 379-86.
24. Maron BJ, Shirani J, Poliac LC, et al. Sudden death in young competitive athletes: clinical, demographic, and pathologic profiles. JAMA 1996;276: 199-204.
25. Maron BJ, Gohman T, Kyle SB, Estes NAM, Link MS. Clinical profile and spectrum of commotio cordis. JAMA 2002;287: 114-26.
26. Corrado D, Thiene G, Nava A, et al. Sudden death in young competitive athletes: clinicopathologic correlations in 22 cases. Am J Med 1990;89: 588-96.
27. Thompson PD. Sudden death in the athlete: atherosclerotic coronary disease. In: Estes NAM, Salem DN, Wang PJ, eds. Sudden Cardiac Death in the Athlete. Armonk, NY: Futura,1998: 588-96.
28. Samenuk D, Link MS, Homoud MK, et al. Adverse cardiovascular events temporally associated with ma huang, an herbal source of ephedrine. Mayo Clin Proc 2002;77: 12-6.
29. Calkins H, Shyr Y, Frumin H, Schork A, Morady F. The value of the clinical history in the differentiation of syncope due to ventricular tachycardia, atrioventricular block, and neurocardiogenic syncope. Am J Med 1995;98: 365-73.
30. Alboni P, Brignole M, Menozzie C, et al. Diagnostic value of history in patients with syncope with or without heart disease. J Am Coll Cardiol 2001;37: 1921-8.
31. Link MS, Wang PJ, Estes NAM. Ventricular arrhythmias in the athlete. Curr Opin Cardiol 2001;16: 30-9.
32. Maron BJ, Moller JH, Seidman CE, et al. Impact of laboratory molecular diagnosis on contemporary diagnostic criteria for genetically transmitted cardiovascular diseases: hypertrophic cardiomyopathy, long QT syndrome, and Marfan syndrome. Circulation 1998;98: 1460-71.
33. Klein GJ, Gersh BJ, Yee R. Electrophysiologic testing: the final court of appeal for diagnosis of syncope? Circulation 1995;92: 1332-3.
34. Graham TP Jr., Bricker JT, James FW, Strong WB. 26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 1: congenital heart disease. J Am Coll Cardiol 1994;24: 867-73.
35. Pelliccia A, Maron BJ, Spataro A, Proschan MA, Spirito P. The upper limit of physiologic cardiac hypertrophy in highly trained elite athletes. N Engl J Med 1991;324: 295-301.
36. Colivicchi F, Ammirati F, Biffi A, Verdile L, Pelliccia A, Santini M. Exercise-related syncope in young competitive athletes without evidence of structural heart disease: clinical presentation and long-term outcome. Eur Heart J 2002;23: 1125-30.
37. Link MS, Homoud MS, Wang PJ, Estes NAM. Cardiac arrhythmias in the athlete: the evolving role of electrophysiology. Curr Sports Med Rep2002;1: 75-85.
38. Oakley C. The electrocardiogram in the highly trained athlete. Cardiol Clin 1992;10: 295-302.
39. Kosinski DJ. Syncope in the athlete. In: Grubb BP, Olshansky B, eds. Syncope: Mechanisms and Management. Armonk, NY: Futura, 1998: 317-35.
40. Pellicia A, Maron B, Spataro A, et al. The upper limit of physiologic cardiac hypertrophy in highly trained athletes. N Engl J Med 1991;324: 295-301.
41. Maron BJ. Structural features of the athlete's heart: as defined by echocardiography. J Am Coll Cardiol 1986;7: 190-203.
42. Basso C, Maron BJ, Corrado D, Thiene G. Clinical profile of congenital coronary artery anomalies with origin from the wrong aortic sinus leading to sudden death in young competitive athletes. J Am Coll Cardiol 2000;35: 1493-501.
43. Frescura C, Basso C, Thiene G, et al. Anomalous origin of coronary arteries and risk of sudden death: a study based on an autopsy population of congenital heart disease. Hum Pathol 1998;29: 689-95.
44. Burke A, Farb A, Virmani R, et al. Sports-related and non-sports-related sudden cardiac death in young adults. Am Heart J 1991;121: 568-75.
45. Sneddon J, Scalia G, Ward D, et al. Exercise-induced vasodepressor syncope. Br Heart J 1994;71: 554-7.
46. Grubb BP. Neurocardiogenic syncope. In: Grubb BP, Olshansky B, eds. Syncope: Mechanisms and Management. Armonk, NY: Futura, 1998: 73-106.
47. Benditt D, Ferguson D, Grubb BP, et al. Tilt table testing for assessing syncope: an American College of Cardiology Consensus document. J Am Coll Cardiol 1996;28: 263-75.
48. Grubb BP, Temsey-Armos PN, Samoil D, Wolfe DA, Hahn H, Elliott L. Tilt table testing in the evaluation and management of athletes with recurrent exercise-induced syncope. Med Sci Sports Exerc 1993;25: 24-8.
49. O'Connor FG, Oriscello RG, Levine BD. Exercise-related syncope in the young athlete: reassurance, restruction or referral? Am Fam Physician 1999;60: 2001-8.
50. Link MS, Wang PJ, Estes NAM. Cardiac arrhythmias and electrophysiologic observations in the athlete. In: Richard A, Williams M, eds. The Athlete and Heart Disease. Philadelphia, PA: Lippincott, Williams & Wilkins; 1998: 197-216.
51. Smith ML, Hudson DL, Graitzer HM, et al. Exercise training bradycardia: the role of autonomic balance. Med Sci Sports Exerc 1989;21: 40-44.
52. Gregoratos G, Cheitlin MD, Conill A, et al. ACC/AHA guidelines for implantation of cardiac pacemakers and antiarrhythmic devices. J Am Coll Cardiol 1998;31: 1175-209.
53. Jackman WM, Wang X, Friday KJ, et al. Catheter ablation of accessory atrioventricular pathways (Wolff-Parkinson-White syndrome) by radiofrequency current. N Engl J Med 1991;324: 1605-11.
54. Sharma AD, Yee R, Guiraudon G, et al. Sensitivity and specificity of invasive and non-invasive testing for risk of sudden death in Wolff-Parkinson-White syndrome. J Am Coll Cardiol 1987;10: 373-81.
55. Zardini M, Yee R, Thakur RK, et al. Risk of sudden arrhythmic death in the Wolff-Parkinson-White syndrome: current perspectives. PACE 1994;17: 966-75.
56. Link MS, Homoud MK, Wang PJ, Estes NAM. Cardiac arrhythmias in the athlete. Cardiol Rev 2001;9: 21-30.
57. Pappone C, Santinelli V, Manguso F, et al. A randomized study of prophylactic catheter ablation in asymptomatic patients with Wolff-Parkinson-White syndrome. N Engl J Med 2003;349: 1803-11.
58. Link MS, Estes NAM. Ventricular arrhythmias. In: Estes NAM, Salem DN, Wang PJ, eds. Sudden Cardiac Death in the Athlete. Armonk, NY: Futura,1998: 253-75.
59. Bigger JT, Reiffel JA, Livelli FD, et al. Sensitivity, specificity, and reproducibility of programmed ventricular stimulation. Circulation1986;73(Suppl. 2): 73-8.
60. Peters S, Reil GH. Risk factors of cardiac arrest in arrhythmogenic right ventricular dysplasia. Eur Heart J 1995;16: 77-80.
61. Wichter T, Martinez-Rubio A, Kottkamp H, et al. Reproducibility of programmed ventricular stimulation in arrhythmogenic right ventricular dysplasia/cardiomyopathy [Abstract]. Circulation 1996;94(Suppl. 1): 626.
62. Prystowsky EN. Electrophysiologic-electropharmacologic testing in patients with ventricular arrhythmias. PACE 1988;11: 225-51.
63. Zipes DP, Garson A Jr. 26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 6: arrhythmias. J Am Coll Cardiol 1994;24: 892-9.
64. DiGirolamo E, Di Iorio C, Leeonzio L, et al. Usefulness of a tilt training program for the prevention of refractory neurocardiogenic syncope in adolescents: a controlled study. Circulation 1999;100: 1798-801.
65. Klein LS, Miles WM. Ablative therapy for ventricular arrhythmias. Prog Cardiovasc Dis 1995;37: 225-42.
66. Calkins H, Kalbfleisch SJ, El-Atassi R, et al. Relation between efficacy of radiofrequency catheter ablation and site of origin of idiopathic ventricular tachycardia. Am J Cardiol 1993;71: 827-33.
67. Corrado D, Leoni L, Link, MS, et al. Implantable cardio-verter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circulation 2003;108: 3084-91.